The Cross-Border Biotech Investment & BD Forum

Biokatalyst and Biolink Capital invite you to an exclusive, high-impact afternoon where the future of global medicine is shaped. Held during the BIO International Convention, this forum is the premier destination for those navigating the vital corridor between U.S. innovation and Asian capital.

3:00-3:40 PST

Navigating the New Logic of Cross-Border Biotech Investment

The biotech financing landscape has fundamentally changed. Join this focused discussion on the new rules of cross-border investment. Hear directly from leading VCs and CEOs who recently closed major financings as they share what investors value in 2026, and how global innovation is being priced today.

Panelist: Sean Hu CEO of Rapafusyn Pharmaceuticals, Lily Zou CEO and Co-Founder, Degron Therapeutics and more is coming

Moderator: Vivian Li Early Stage Investor K2VC

3:40-4:00 PST

One Topic

4:15-4:35 PST

Insights into China's Innovative Drug R&D and Transaction Trends

Speaker：Zairan Liu ｜ Chief International Business

4:35-5:15 PST

Navigating the New Logic of Cross-Border Biotech BD

Business Development is no longer just about partnering — it has become a core financing and growth strategy in biotech. Join BioKatalyst and industry leaders for a discussion on how cross-border BD is evolving amid changing FDA expectations, geopolitical shifts, and global capital trends.

Panelist: John Wang SVP/Chief Strategy Officer, Gan & Lee Pharmaceutical, Hai Dai Chief Innovation Officer, Head of Investment, Viva Biotech and more is coming

Moderator: Seamus Jiang Managing Director, China/U.S.Cross-border Deals Leader at PwC US

5:15-6:00 PST Networking with Wine and Snacks

this forum is your go-to spot. Let’s make some powerful connections, share groundbreaking ideas, and push biotech to the next level together!

Know what’s Happening Next — before everyone else does.

Get App

Host or Publisher BioKatalyst